Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3004268	li-prot-fr	— (—)	70	79	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Symptoms and signs involving the nervous and musculoskeletal systems

16.37

42.61

1.0

1.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

16.52

20.87

1.0

1.2

—

Nerve, nerve root and plexus disorders

5.55

12.70

1.3

1.0

—

Neurological diseases

10.61

8.65

1.2

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

4.09

8.00

1.1

1.2

—

Headache

4.68

7.02

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3.89

6.94

1.4

1.0

—

ILD medications

3.61

6.84

1.1

1.2

—

Other disorders of lacrimal gland

8.67

6.54

1.0

1.1

—

Other neurological diseases

4.16

6.46

1.3

1.1

—

Bacterial infection, other or unspecified

5.79

6.03

1.4

1.0

—

Metabolic disorders

3.81

5.92

1.3

1.1

—

Asthma, hospital admission 2, infections

4.90

5.74

1.1

1.2

—

Asthma-related infections

4.90

5.74

1.1

1.2

—

Mood disorders, excluding more controls

3.58

5.69

1.0

1.2

—

Neurotic, stress-related and somatoform disorders

3.42

5.63

1.1

1.2

—

Anxiety disorders

3.40

5.59

1.1

1.2

—

Codes for special purposes

4.99

5.54

1.3

1.1

—

Provisional assignment of new diseases of uncertain etiology

4.99

5.54

1.3

1.1

—

Mood [affective] disorders

3.32

5.52

1.0

1.2

—

Mood disorders

3.31

5.50

1.0

1.2

—

First line medication for Crohn's disease

3.24

5.48

1.3

1.1

—

Asthma, hospital admissions , main diagnosis only

3.42

5.46

1.1

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.30

5.45

1.1

1.2

—

Anxiety disorders, excluding more controls

3.64

5.42

1.1

1.2

—

Bacterial infection, other or unspecified

5.01

5.41

1.4

1.0

—

Disorders of lacrimal system

6.18

5.36

1.0

1.1

—

Asthma (only as main-diagnosis)

3.94

5.15

1.1

—

Other bacterial diseases

3.25

5.10

1.3

1.0

—

Asthma (only as main-diagnosis), excluding more controls

3.89

5.05

1.1

—

Anxiety (asthma-related co-morbidities)

3.75

5.04

1.1

1.2

—

Symptoms and signs involving the urinary system

3.69

4.92

1.4

1.0

—

4.96

4.89

1.1

1.2

—

All anxiety disorders

3.61

4.83

1.1

1.2

—

Asthma (diagnoses ohter than nonallergic)

3.15

4.77

1.1

1.2

—

Chronic lower respiratory diseases

2.90

4.64

1.1

1.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

4.63

1.0

1.1

—

Covid-19 confirmed case

6.11

4.59

1.5

1.1

—

Other bacterial diseases

3.19

4.59

1.4

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

3.22

4.58

1.3

1.1

—

Asthma (mode)

3.64

4.56

1.1

—

Autoimmune diseases excluding thyroid diseases

3.21

4.55

1.3

1.1

—

Asthma

3.57

4.40

1.1

—

Oral corticosteroids

2.97

4.37

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

3.94

4.37

1.1

—

Asthma, excluding more controls

3.55

4.37

1.1

—

Asthma-related pneumonia

7.49

4.34

1.2

1.1

—

Asthma-related pneumonia or sepsis

7.49

4.34

1.2

1.1

—

Asthma, hospital admissions 3, pneumonia

7.49

4.34

1.2

1.1

—

General symptoms and signs

3.13

4.27

1.4

1.0

—

Cystitis

3.15

4.12

1.2

1.0

—

Epilepsy

5.87

4.11

1.1

—

Other diseases of urinary system

2.96

4.08

1.4

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

8.01

4.05

1.6

1.1

—

Dizziness and giddiness

3.30

4.02

1.0

1.2

—

Systemic connective tissue disorders

6.43

3.98

1.0

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

4.95

3.96

1.5

1.1

—

Inflammatory bowel disease treatment related agents

2.73

3.95

1.1

1.2

—

Diseases of middle ear and mastoid

3.37

3.89

1.1

—

Bacterial Sepsis

4.95

3.87

1.5

1.0

—

Liquid cancers, helper endpoint

5.45

3.83

1.7

1.0

—

Other symptoms and signs involving cognitive functions and awareness

4.77

3.80

1.2

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

8.76

3.77

1.0

1.1

—

Other symptoms and signs involving the urinary system

12.01

3.76

1.8

1.2

—

Asthma and allergy, excluding more controls

11.85

3.73

1.2

—

Asthma and allergy

11.85

3.73

1.2

—

Cerebrovascular diseases (FINNGEN)

6.37

3.71

1.1

1.0

—

Asthma, including avohilmo

2.63

3.70

1.1

—

Implicit viral Sepsis

6.67

3.67

1.8

1.0

—

Depression

2.84

3.65

1.0

1.2

—

Obesity related asthma

5.63

3.65

1.0

1.1

—

Gastro-oesophageal reflux disease

3.18

3.63

1.0

1.2

—

Fever of other and unknown origin

4.11

3.61

1.6

1.0

—

Allergic asthma (mode)

6.53

3.61

1.1

—

Allergic asthma (mode), excluding more controls

6.53

3.61

1.1

—

Any mental disorder

2.78

3.58

1.1

1.2

—

Implicit viral Sepsis

7.78

3.55

1.9

1.0

—

Viral Sepsis

7.78

3.55

1.9

1.0

—

Other systemic involvement of connective tissue

7.78

3.55

1.0

1.1

—

Migraine

4.05

3.52

1.0

1.1

—

Other anxiety disorders

4.00

3.51

1.2

1.1

—

STROKE

4.08

3.43

1.1

1.2

—

Hypertension, essential

3.14

3.40

1.1

1.2

—

Episodal and paroxysmal disorders

2.68

3.39

1.1

1.2

—

Pain, not elsewhere classified

5.72

3.33

1.1

1.0

—

Visual disturbances and blindness

3.64

3.28

1.4

1.1

—

Bacterial pneumoniae

4.96

3.28

1.7

1.1

—

Dorsalgia

2.75

3.26

1.1

1.2

—

Phobic anxiety disorders

8.56

3.26

1.3

—

Other disorders of fluid, electrolyte and acid-base balance

6.67

3.24

1.7

1.1

—

Other acute lower respiratory infections

3.57

3.21

1.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.58

3.18

1.1

1.2

—

Septicaemia

4.68

3.17

1.2

1.0

—

Autoimmune diseases related-to ILD

2.68

3.15

1.1

1.2

—

Hyperlipidaemia, other/unspecified

5.26

3.11

1.1

—

Injuries to the thorax

4.50

3.10

1.6

1.1

—

All chronic kidney diseases

3.75

3.05

1.2

1.0

—

Certain disorders involving the immune mechanism

7.50

3.05

1.2

1.1

—

Other disorders of skin and subcutaneous tissue

3.21

3.04

1.2

—

Diabetes mellitus

2.52

3.04

1.1

—

Migraine with aura

5.83

3.02

1.0

1.2

—

Any reimbursement code in KELA

3.76

3.01

1.2

1.1

—

Mental disorders, not otherwise specified

10.01

2.98

1.2

—

Somatoform disorder

10.01

2.98

1.0

1.2

—

Undetermined asthma, excluding more controls

10.00

2.98

1.0

1.2

—

Undetermined asthma

10.00

2.98

1.0

1.2

—

Bacterial pneumonia (organism specified)

4.30

2.95

1.7

1.1

—

Benzodiazepine use

2.48

2.91

1.1

1.2

—

2.69

2.91

1.4

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.69

2.91

1.4

1.1

—

Neurological diseases, wide definition

7.03

2.90

1.3

1.0

—

Periapical abscess

3.44

2.89

1.1

1.2

—

Diseases of the skin and subcutaneous tissue

2.58

2.87

1.2

1.0

—

Pneumonia, organism unspecified

2.61

2.87

1.4

1.1

—

Other and unspecified polyneuropathies, also in other diseases

6.67

2.86

1.2

1.1

—

Other and unspecified nerve root and plexus disorders, also in other diseases

6.67

2.86

1.8

1.0

—

Gastroduodenal ulcer

6.65

2.86

1.2

1.1

—

Bacterial pneumonia, not elsewhere classified

4.70

2.85

1.8

1.1

—

Intestinal infectious diseases

2.38

2.85

1.3

1.1

—

Stroke, excluding SAH

3.84

2.84

1.1

—

Other systemic involvement of connective tissue (FG)

5.32

2.83

1.0

—

Concussion

6.99

2.83

1.0

—

Intestinal infectious diseases

2.48

2.83

1.4

1.1

—

Visual disturbances

3.33

2.80

1.4

1.1

—

Explicit Sepsis

4.00

2.80

1.2

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

2.77

2.79

1.2

1.1

—

Other viral diseases, not elsewhere classified

4.42

2.78

1.5

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

2.99

2.77

1.2

1.0

—

Anaemias

5.71

2.75

1.7

1.1

—

Other viral diseases

3.54

2.75

1.5

1.1

—

Diabetes, varying definitions

2.45

2.75

1.1

—

Other disorders of urethra and urinary system

2.84

2.73

1.4

1.0

—

Diagnoses used for exclusion with ILD

5.00

2.72

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

6.00

2.69

2.2

1.0

—

Implicit Sepsis

2.69

1.4

1.1

—

Other dorsopathies, not elsewhere classified

2.54

2.69

1.1

1.2

—

Cerebrovascular diseases

3.12

2.68

1.1

1.2

—

Diseases of the ear and mastoid process

2.33

2.65

1.1

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.58

2.64

1.4

1.1

—

Endocrine, nutritional and metabolic diseases

2.71

2.63

1.1

—

Disorders of eyelid, lacrimal system and orbit

2.53

2.61

1.0

1.2

—

Disorders of refraction and accommodation

4.65

2.58

1.0

1.1

—

Tonsillectomy and adenotomy

2.88

2.56

1.0

1.1

—

Childhood asthma (age<16)

7.88

2.55

1.2

1.0

—

Childhood asthma (age<16), excluding more controls

7.88

2.55

1.2

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.38

2.54

1.1

—

Malaise and fatigue

3.62

2.51

1.1

1.0

—

Implicit bacterial Sepsis

3.94

2.49

1.8

1.0

—

Used for control exclusion in common control thyroid runs

2.53

2.49

1.4

1.1

—

Strabismus

4.37

2.46

1.0

1.1

—

Impacted teeth

4.45

2.46

1.0

1.1

—

Asthma, unspecified (mode)

3.27

2.45

1.0

1.1

—

Hypertensive diseases (excluding secondary)

3.42

2.45

1.1

1.0

—

Psychiatric diseases

2.50

2.44

1.1

—

Asthma, unspecified (mode), excluding more controls

3.25

2.44

1.0

1.1

—

Type 2 diabetes

2.36

2.43

1.1

—

Dorsopathies

2.40

2.41

1.1

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.53

2.40

1.4

1.1

—

Other headache syndromes

3.33

2.38

1.0

1.1

—

Disturbances of skin sensation

4.12

2.36

1.1

—

Stroke, including SAH

3.15

2.35

1.1

1.3

—

All kidney diseases

2.28

2.35

1.4

1.1

—

Intracranial trauma

5.27

2.34

1.0

—

Injuries to the wrist and hand

2.26

2.33

1.1

—

Implicit bacterial Sepsis

3.64

2.31

1.8

1.0

—

Acute bronchitis

4.04

2.31

1.1

—

Pure hypercholesterolaemia

3.11

2.28

1.1

—

Obesity due to excess calories

2.94

2.27

1.0

1.2

—

Fall on and from stairs and steps

4.62

2.27

1.3

1.1

—

Hypertensive diseases

2.62

2.24

1.1

1.2

—

Other/unspecified dorsalgia

3.45

2.24

1.0

1.1

—

Hypertension

2.62

2.24

1.1

1.2

—

Hard cardiovascular diseases

2.58

2.22

1.1

1.2

—

Other antidepressants

2.29

2.21

1.2

—

Unspecified acute lower respiratory infection

5.56

2.21

1.4

1.1

—

All influenza

5.55

2.21

1.2

1.1

—

Fracture of lumbar spine and pelvis

5.55

2.21

1.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2.27

2.21

1.4

1.1

—

Other viral diseases, not elsewhere classified

5.54

2.21

1.8

1.1

—

Hypothyroidism, strict autoimmune

2.63

2.18

1.1

—

Other hearing loss

5.44

2.17

1.0

1.1

—

Oedema, not elsewhere classified

4.23

2.12

1.5

1.0

—

Implicit Sepsis

2.51

2.08

1.5

1.1

—

Influenza and pneumonia

2.16

2.07

1.4

1.1

—

Ischaemic Stroke, excluding all haemorrhages

3.31

2.07

1.1

—

Otitis media, unspecified

5.12

2.07

1.2

1.3

—

Panic disorder

5.00

2.07

1.4

1.2

—

Migraine with aura and triptan purchases

5.00

2.07

1.0

1.2

—

Other diseases of blood and blood-forming organs, wide

5.00

2.07

1.6

1.0

—

Type 2 diabetes, wide definition

2.56

2.07

1.1

1.2

—

Type 1 diabetes, wide definition, subgroup 1

5.00

2.07

1.0

—

Unspecified mental disorder

2.90

2.07

1.1

—

Recurrent or chronic depression

3.01

2.05

1.0

—

Persons with potential health hazards related to communicable diseases

2.88

2.04

1.2

1.1

—

Bronchitis

2.14

2.03

1.2

1.1

—

Organic, including symptomatic, mental disorders

3.56

1.98

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.40

1.98

1.2

1.1

—

Sequelae of cerebrovascular disease

4.79

1.97

1.0

1.1

—

Hypothyroidism, drug reimbursement

5.04

1.96

1.2

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

2.15

1.96

1.4

1.1

—

Other extrapyramidal and movement disorders in other diseases

4.55

1.94

1.0

1.1

—

All pneumoniae

2.14

1.94

1.4

1.1

—

Type 1 diabetes, wide definition

4.54

1.94

1.0

—

Fracture of rib(s), sternum and thoracic spine

3.75

1.93

1.2

1.1

—

Extrapyramidal and movement disorders

3.75

1.93

1.0

1.1

—

Complications of medical and surgical care

2.35

1.90

1.2

1.1

—

Suppurative and unspecified otitis media

2.95

1.90

1.1

—

Nausea and vomiting

3.67

1.89

1.0

1.1

—

Renal tubulo-interstitial diseases

2.22

1.89

1.4

1.1

—

Autoimmune diseases

2.24

1.89

1.4

1.1

—

Obesity

2.32

1.87

1.0

1.2

—

Use of hypnotics and sedatives

2.14

1.87

1.1

1.2

—

Obesity and other hyperalimentation

2.31

1.86

1.0

1.2

—

Other septicaemia

3.61

1.86

1.3

1.0

—

Ischaemic heart disease, wide definition

2.52

1.84

1.2

—

Deforming dorsopathies

3.53

1.83

1.0

1.1

—

Covid-19 suspected case

4.17

1.82

1.0

1.2

—

Other diseases of intestines

2.06

1.82

1.3

1.1

—

Sub-endpoint used in defining T1D endpoints

3.47

1.80

1.0

1.1

—

Asthma/COPD (KELA code 203)

2.18

1.80

1.1

1.2

—

Contact with and exposure to communicable diseases

3.03

1.79

1.1

—

Nonsuppurative otitis media

3.46

1.77

1.2

—

Diseases of the eye and adnexa

2.33

1.76

1.1

—

Other viral diseases

2.91

1.71

1.7

1.1

—

Other noninfective gastroenteritis and colitis

3.84

1.71

1.2

1.1

—

Other nutritional deficiencies

2.22

1.70

1.0

1.2

—

Diseases of oesophagus, stomach and duodenum

2.04

1.70

1.1

1.2

—

Other disorders of ear

2.13

1.69

1.1

1.2

—

Unspecified haematuria

3.32

1.69

2.0

1.1

—

Oxycodone

2.88

1.67

1.6

1.0

—

Senile cataract

2.55

1.67

1.1

1.3

—

Embedded and impacted teeth

2.89

1.66

1.0

1.2

—

All dysplastic lesions of the cervix uteri, vagina or vulva

3.11

1.63

1.0

1.1

—

Falls/tendency to fall

1.98

1.62

1.1

1.2

—

HSIL lesion of the cervix uteri, vagina or vulva

3.57

1.61

1.0

1.1

—

Type 1 diabetes

3.57

1.61

1.0

—

Antihypertensive medication - note that there are other indications

2.27

1.59

1.1

1.2

—

Symptoms and signs involving speech and voice

3.00

1.58

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.68

1.57

1.0

1.1

—

Pain in joint

2.61

1.53

1.0

—

Malignant neoplasm, wide definition for exclusion

2.12

1.52

1.5

1.0

—

Other functional intestinal disorders

2.60

1.50

1.6

1.1

—

Fitting and adjustment of other devices

3.22

1.46

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.26

1.45

1.0

1.1

—

Rotator cuff syndrome

2.39

1.45

1.0

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

2.37

1.44

1.1

—

Disorders of lens

2.31

1.44

1.1

1.2

—

Umbilical hernia

3.13

1.44

1.8

1.2

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3.13

1.44

1.0

1.1

—

Obesity, other/unspecified

2.73

1.43

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2.35

1.43

1.0

1.1

—

DVT of lower extremities and pulmonary embolism

2.72

1.42

1.7

1.1

—

Childhood allergy (age < 16)

3.17

1.42

1.2

1.1

—

Disorders of the thyroid gland

1.91

1.41

1.1

1.2

—

Persons encountering health services for specific procedures and health care

1.88

1.41

1.4

1.1

—

Cholecystectomy

2.21

1.41

1.1

—

Low back pain

2.24

1.40

1.1

1.2

—

Other diseases of upper respiratory tract

1.89

1.40

1.1

1.2

—

Other reaction to severe stress, and adjustment disorders

2.61

1.36

1.2

1.1

—

Disorders of vestibular function (Vertigo)

2.37

1.36

1.0

1.1

—

Other and unspecified effects of external causes

2.94

1.36

1.0

1.1

—

Retinal detachments and breaks

2.94

1.36

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

1.92

1.34

1.1

—

All dysplastic lesions of the cervix uteri

2.92

1.34

1.0

1.1

—

Schizophrenia or delusion, excluding more controls

2.91

1.34

1.0

1.1

—

Ischemic heart diseases

2.13

1.33

1.1

1.2

—

Other abnormal products of conception

2.65

1.32

1.0

1.1

—

Erysipelas

2.44

1.31

1.5

1.0

—

COPD/asthma/ILD related infections

1.95

1.31

1.1

—

COPD/asthma related infections

1.95

1.31

1.1

—

Transient ischemic attack

2.56

1.30

1.0

1.1

—

Insulin, intermediate and long-acting

2.36

1.29

1.0

1.2

—

Melanocytic naevi

2.78

1.28

1.4

1.0

—

Type 2 diabetes, definitions combined

1.96

1.28

1.2

—

Cardiovascular diseases

2.11

1.27

1.2

1.0

—

Necrosis of pulp, including avohilmo

2.08

1.26

1.0

1.2

—

Disorders of skin appendages

2.28

1.26

1.0

1.1

—

Second line medication for Crohn's disease

2.04

1.26

1.1

—

GASTRO-related operations

2.12

1.26

1.2

1.1

—

Any gastric operation

2.12

1.26

1.2

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

1.94

1.25

1.2

—

Hernia of abdominal wall

2.40

1.24

1.7

1.1

—

1.84

1.23

1.1

—

ILD medications: immunosuppressive drugs

2.19

1.22

1.1

1.2

—

Conductive and sensorineural hearing loss

2.11

1.22

1.1

1.2

—

Hernia

1.89

1.21

1.3

1.1

—

Lumbar disc prolapse

2.19

1.21

1.1

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

1.93

1.21

1.1

1.2

—

Type 2 diabetes, strict (exclude DM1)

1.91

1.21

1.2

—

Chronic diseases of tonsils and adenoids

1.94

1.19

1.0

1.2

—

Kela-code for severe mental illness

2.31

1.18

1.0

—

Cholelithiasis, broad definition with cholecystitis

1.92

1.17

1.1

1.2

—

Disorders of vitreous body

0.00

1.16

0.0

1.1

—

Disorders of vitreous body and globe

0.00

1.16

0.0

1.1

—

Hypothyroidism, other/unspecified

1.86

1.15

1.1

1.2

—

Disorders of gallbladder, biliary tract and pancreas

1.86

1.15

1.1

1.2

—

Disorders of choroid and retina

2.03

1.13

1.0

1.2

—

Carpal tunnel syndrome

2.37

1.13

1.0

—

Diseases of inner ear

2.33

1.12

1.0

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.32

1.11

1.0

1.1

—

Procreative management

2.45

1.10

1.2

1.1

—

Disorders of breast

2.27

1.10

1.1

1.0

—

Benign neoplasms

1.76

1.10

1.2

1.1

—

Hypothyroidism and >3 levothyroxin purchases

2.57

1.10

1.2

1.1

—

Hypothyroidism, levothyroxine purchases

2.57

1.10

1.2

1.1

—

Non-selective monoamine reuptake inhibitors

2.41

1.10

1.4

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.97

1.10

1.1

1.2

—

Hypothyroidism (congenital or acquired)

2.57

1.10

1.2

1.1

—

Spontaneous abortion

2.25

1.09

1.0

—

Ovarian cyst

2.24

1.08

1.0

1.1

—

Soft tissue disorders

1.76

1.08

1.1

—

Menorrhagia

2.52

1.08

1.0

—

Depression or dysthymia

2.07

1.07

1.0

—

Dysplasia of cervi uteri

2.41

1.07

1.0

—

Injuries to the shoulder and upper arm

1.89

1.06

1.0

1.2

—

Diabetes medication

1.77

1.06

1.1

—

Acute tubulo-interstitial nephritis

1.99

1.04

1.0

1.1

—

Certain infectious and parasitic diseases

1.88

1.04

1.2

1.0

—

Heart failure, not strict

1.97

1.04

1.2

—

Sensorineural hearing loss

1.97

1.04

1.1

1.2

—

Insulin, fast-acting

2.27

1.03

1.0

1.1

—

Excessive earwax

2.07

1.03

1.3

1.0

—

Pregnancy with abortive outcome

1.96

1.03

1.1

—

Acute appendicitis

1.91

1.02

1.0

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.06

1.02

1.1

—

Tramadol

1.88

1.00

1.1

1.0

—

Other soft tissue disorders, not elsewhere classified

1.77

1.00

1.5

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.80

0.99

1.1

1.0

—

Shoulder lesions

1.88

0.99

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

2.03

0.99

1.1

1.3

—

Other external causes of accidental injury

1.90

0.99

1.0

1.1

—

Triptan medication for migraine, min. 3 purchases

1.86

0.99

1.0

1.1

—

Atopic dermatitis, strict definition with reimbursement

2.19

0.99

1.2

1.1

—

Other intervertebral disc disorders

1.87

0.99

1.1

1.2

—

Injuries to the hip and thigh

0.00

0.98

0.0

1.1

—

Coxibs

2.43

0.97

1.2

1.0

—

Pain in throat and chest

1.80

0.97

1.1

1.2

—

Injuries to the ankle and foot

1.81

0.97

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.74

0.97

1.1

—

Other and unspecified tonsillitis

1.96

0.97

1.1

1.2

—

Persons encountering health services in other circumstances, wide

1.68

0.95

1.3

1.1

—

Spondylosis

2.22

0.93

1.2

—

Persons encountering health services in other circumstances

2.21

0.93

1.7

1.1

—

Transport accidents

2.15

0.91

1.0

1.1

—

Triptan medication for migraine, single purchase ok

1.73

0.89

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.73

0.89

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.92

0.89

1.0

1.2

—

Parasetamol

1.88

0.88

1.2

1.1

—

Disorders of other endocrine glands

2.03

0.88

2.0

1.0

—

Insulin medication

1.87

0.87

1.0

1.2

—

L04AX Other immunosuppressants

1.86

0.87

1.1

—

Acute appendicitis, no complications

1.85

0.87

1.0

1.2

—

Venous thromboembolism

2.00

0.86

1.7

1.1

—

Medical observation and evaluation for suspected diseases and conditions

1.86

0.86

1.6

1.1

—

Any event in cancer register

1.72

0.86

1.6

1.0

—

Pain in limb

1.75

0.85

1.5

1.1

—

Medical abortion

1.81

0.84

1.0

1.1

—

Chronic sinusitis

1.93

0.84

1.2

—

Statin medication

1.80

0.84

1.3

1.2

—

Other heart diseases

1.96

0.84

1.0

—

Dental pulpitis, including avohilmo

1.65

0.83

1.0

1.2

—

Open wound of wrist and hand

1.89

0.82

1.0

1.2

—

Persons encountering health services in circumstances related to reproduction

1.74

0.81

1.3

1.2

—

Angina pectoris

1.90

0.81

1.2

—

Premature rupture of membranes

0.00

0.81

0.0

1.1

—

Nutritional anaemias

1.87

0.81

1.0

1.1

—

Appendicitis, broad definition

1.74

0.80

1.0

1.2

—

Diseases of appendix

1.73

0.79

1.0

1.2

—

Coxarthrosis, primary, with hip surgery

0.00

0.79

0.0

1.1

—

Other and unspecified disorders of vitreous body

0.00

0.79

0.0

1.1

—

Glucosamine medication

0.00

0.78

0.0

1.1

—

Biguanides

1.66

0.78

1.2

1.1

—

Major coronary heart disease event

1.75

0.77

1.0

1.2

—

Complications of procedures, not elsewhere classified

1.72

0.77

1.2

1.1

—

Sleep disorders (combined)

1.60

0.77

1.0

1.1

—

Other (not insulin) diabetes medications

1.66

0.77

1.2

1.1

—

Atopic dermatitis, strict definition

2.13

0.75

1.2

1.1

—

Malignant neoplasm

1.74

0.75

1.7

1.0

—

Schizophrenia or delusion

2.08

0.74

1.0

1.1

—

Schizophrenia, schizotypal and delusional disorders

2.08

0.74

1.0

1.1

—

Insulin, fast-acting or short human

2.08

0.74

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

1.66

0.74

1.1

—

Selective serotonin reuptake inhibitors

1.65

0.74

1.1

1.2

—

Fall on same level

1.54

0.74

1.1

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

1.63

0.73

1.2

1.1

—

Renal failure

2.01

0.72

2.0

1.0

—

Spondylopathies

1.74

0.70

1.1

1.2

—

Abnormal findings on examination of blood, without diagnosis

1.91

0.70

1.2

1.3

—

Care involving use of rehabilitation procedures

1.65

0.67

1.1

—

Diseases of the musculoskeletal system and connective tissue

1.67

0.67

1.3

1.0

—

Infections of the skin and subcutaneous tissue

1.61

0.66

2.0

1.0

—

Pain (limb, back, neck, head abdominally)

1.74

0.65

1.1

1.0

—

Cholelithiasis

1.64

0.65

1.1

1.2

—

Sciatica+with lumbago

1.70

0.63

1.0

1.2

—

Erysipelas

1.70

0.62

1.8

1.0

—

Bleeding

1.63

0.62

1.3

1.2

—

Atopic dermatitis

1.60

0.61

1.1

—

Inflammatory diseases of female pelvic organs

1.59

0.61

1.1

—

Other specified/unspecified arthritis

0.00

0.60

0.0

1.1

—

Other arthritis (FG)

0.00

0.60

0.0

1.0

—

Other benign neoplasms of skin

0.00

0.60

0.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.55

0.60

1.3

1.1

—

Exposure to unspecified factor

1.51

0.59

1.3

1.1

—

Preterm labour and delivery

0.00

0.58

0.0

1.1

—

Other retinal disorders

1.73

0.58

1.0

1.1

—

Temporomandibular joint disorders, including avohilmo

1.74

0.58

1.0

1.1

—

Sleep apnoea

1.58

0.57

1.0

1.2

—

Noninfective enteritis and colitis

1.62

0.55

1.2

1.1

—

Leiomyoma of uterus

1.62

0.55

1.0

—

Dermatitis and eczema

1.46

0.55

1.4

1.1

—

Polycystic ovarian syndrome, consortium definition

1.48

0.54

1.1

—

Gastrointestinal diseases

1.58

0.54

1.3

1.1

—

Acute upper respiratory infections

1.48

0.53

1.2

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.61

0.51

1.3

1.1

—

Cardiac arrhythmias

1.57

0.49

1.0

—

Irregular menses

1.58

0.49

1.1

—

Dyspnoea

1.51

0.49

1.1

1.2

—

Abnormalities of breathing

1.49

0.49

1.1

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.51

0.47

1.1

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

1.45

0.47

1.1

1.2

—

Caries of enamel

0.59

0.46

1.0

1.1

—

Artrosis, including avohilmo

1.48

0.44

1.0

1.2

—

Viral infections characterized by skin and mucous membrane lesions

1.45

0.43

1.6

1.1

—

Opioids

1.42

0.43

1.1

1.0

—

Cough

1.63

0.43

1.0

1.1

—

Other menopausal disorders

0.00

0.43

0.0

1.0

—

Gestational diabetes (for exclusion)

1.58

0.42

1.0

1.1

—

Lower back pain or/and sciatica

1.40

0.42

1.1

—

Accidents

1.38

0.42

1.0

1.1

—

Malignant neoplasm of prostate

0.00

0.42

0.0

1.1

—

Diabetes mellitus in pregnancy

1.52

0.41

1.0

1.1

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.41

0.0

1.1

—

L02BG Aromatase inhibitors

0.00

0.41

0.0

1.1

—

Other fall from one level to another

0.00

0.41

0.0

1.1

—

Sulfasalazine

0.00

0.41

0.0

1.1

—

Acute alcohol intoxication

0.00

0.41

0.0

1.1

—

malignant neoplasm of male genital organs

0.00

0.40

0.0

1.1

—

Benign lipomatous neoplasm

0.00

0.40

0.0

1.1

—

Any death

1.43

0.39

1.2

—

Other and unspecified dermatitis

1.43

0.39

1.8

1.1

—

Unspecified fall

1.41

0.38

1.0

1.2

—

External causes of morbidity and mortality

1.50

0.37

1.0

1.1

—

Chronic apical periodontitis

1.37

0.37

1.0

1.2

—

Certain infectious and parasitic diseases

1.43

0.36

1.2

1.0

—

Injuries to the knee and lower leg

1.34

0.36

1.0

1.2

—

Abdominal and pelvic pain

1.38

0.35

1.2

—

Symptoms and signs involving the digestive system and abdomen

1.38

0.35

1.2

—

Fall on same level involving ice and snow

1.40

0.35

1.0

1.2

—

Persons encountering health services for examination and investigation

1.37

0.35

1.2

1.1

—

Acute sinusitis

1.39

0.35

1.2

—

Dermatophytosis

1.36

0.34

1.2

—

Dermatitis

1.36

0.34

1.8

1.1

—

Excessive attrition of teeth

1.33

0.33

1.2

—

COPD differential diagnosis

1.40

0.32

1.0

1.1

—

ILD differential diagnosis

1.40

0.32

1.0

1.1

—

Solid cancers, helper endpoint

1.25

0.29

1.4

1.0

—

Sleep disorders

1.34

0.29

1.4

1.1

—

Insomnia

1.32

0.28

1.4

1.1

—

Neoplasms

1.29

0.27

1.2

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.31

0.26

1.4

1.1

—

Sleep apnoea, including avohilmo

1.32

0.26

1.0

1.2

—

Other specific joint derangements/joint disorders

1.26

0.26

1.0

1.2

—

Chronic periodontitis, including avohilmo

1.26

0.26

1.0

1.2

—

Periodontitis

1.25

0.26

1.0

1.2

—

Arthropathies

1.27

0.24

1.1

1.2

—

Examination and observation for other reasons

1.38

0.24

1.2

1.1

—

Noninflammatory disorders of female genital tract

1.32

0.24

1.4

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.36

0.23

1.2

—

Coronary atherosclerosis

1.32

0.23

1.4

1.2

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.32

0.23

1.0

1.1

—

Contraceptive management

1.30

0.23

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

1.28

0.23

1.1

—

Varicose veins

1.26

0.22

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

1.22

0.22

1.0

1.3

—

Fracture of lower leg, including ankle

1.24

0.22

1.0

1.2

—

Outcome of delivery

0.00

0.22

0.0

1.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

0.22

0.0

1.0

—

Paracetamol or NSAID medication

0.00

0.22

0.0

1.0

—

Later onset COPD

0.00

0.21

0.0

1.1

—

Disorders of tooth development and eruption

0.00

0.21

0.0

1.1

—

Fracture of femur

0.00

0.21

0.0

1.1

—

Non-invasive ventilation

0.00

0.21

0.0

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.21

0.0

1.1

—

Operations 2 for CAVS

0.00

0.21

0.0

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.21

0.0

1.1

—

Calcific aortic valvular stenosis, operated

0.00

0.21

0.0

1.1

—

Calcific aortic valvular stenosis

0.00

0.21

0.0

1.1

—

Aortic aneurysm

0.00

0.21

0.0

1.1

—

Primary open-angle glaucoma, strict

0.00

0.21

0.0

1.1

—

D07AA Corticosteroids, weak (group I)

0.00

0.21

0.0

1.2

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

1.2

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.21

0.0

1.2

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.21

0.0

1.1

—

Poor fetal growth

0.00

0.21

0.0

1.1

—

Emotionally unstable personality disorder

0.00

0.21

0.0

1.2

—

Salpingitis and oophoritis

0.00

0.21

0.0

1.0

—

Acute and subacute iridocyclitis

0.00

0.21

0.0

1.1

—

Anterior Iridocyclitis

0.00

0.21

0.0

1.1

—

Primary coxarthrosis, bilateral

0.00

0.21

0.0

1.1

—

Reimbursement for rheumatic diseases

1.19

0.21

1.2

1.0

—

Disorders of psychological development

0.00

0.21

0.0

1.1

—

Postmenopausal atrophic vaginitis

0.00

0.21

0.0

1.0

—

Ganglion

0.00

0.21

0.0

1.1

—

Fibroblastic disorders

0.00

0.21

0.0

1.1

—

Coronary artery bypass grafting

0.00

0.21

0.0

1.1

—

Diabetic maculopathy

0.00

0.21

0.0

1.2

—

Acute alcohol intoxication, ICD10

0.00

0.21

0.0

1.1

—

L04AA Selective immunosuppressants

0.00

0.21

0.0

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

0.21

0.0

1.1

—

Benign neoplasm: Colon, unspecified

0.00

0.21

0.0

1.1

—

Percutaneous Coronary Intervention

1.27

0.21

1.0

1.2

—

Coronary revascularization (ANGIO or CABG)

1.27

0.20

1.0

1.2

—

Tooth eruption problems

0.00

0.20

0.0

1.2

—

Redundant prepuce, phimosis and paraphimosis

0.00

0.20

0.0

1.4

—

Other disorders of amniotic fluid and membranes

0.00

0.20

0.0

1.1

—

Exposure to other specified factors

0.76

0.17

1.0

1.2

—

Constipation

1.18

0.17

1.5

1.1

—

Mycoses

1.14

0.16

1.3

1.1

—

Codeine

1.11

0.15

1.1

1.0

—

Injuries to the head

1.19

0.14

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.18

0.11

1.5

1.1

—

Diseases of the respiratory system

1.14

0.10

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.16

0.10

1.0

1.2

—

Intracranial injury

1.13

0.10

1.0

1.2

—

Other pulmonary diagnosis

1.16

0.09

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

1.16

0.09

1.0

1.1

—

Emergency coronary revascularization (for ACS)

1.07

0.09

1.0

1.2

—

Appendectomy

1.06

0.08

1.0

1.1

—

Arthrosis

0.83

0.08

1.0

1.2

—

Gingivitis and periodontal diseases

1.09

0.08

1.1

1.2

—

Disorders of conjunctiva

0.83

0.07

1.0

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.08

0.07

1.2

1.1

—

Finngen Rheumatological endpoints

1.07

0.07

1.1

1.2

—

Codeine or tramadol medication

1.06

0.00

1.1

—

Vocal cord dysfunction

0.00

0.0

1.0

—

Puerperal sepsis

0.00

0.0

1.1

—

Other joint disorders

1.01

0.00

1.0

1.2

—

L04AD Calcineurin inhibitors

0.00

0.0

1.2

—

Cardiomyopathy

0.00

0.0

1.0

—

Caries of dentine, including avohilmo

0.91

0.00

1.0

1.2

—

Alcohol abuse, main dg

0.00

0.0

1.1

—

Non-small cell lung cancer, including Hilmo

0.00

0.0

1.0

—

Hyperparathyroidism

0.00

0.0

1.0

—

Dentofacial anomalies [including malocclusion]

0.94

0.00

1.0

1.1

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.2

—

Other keratitis

0.00

0.0

1.2

—

Excessive vomiting in pregnancy

0.00

0.0

1.3

—

Hypertensive Heart Disease

0.00

0.0

1.1

—

Injuries to the elbow and forearm

0.84

0.00

1.0

1.2

—

Plantar fascial fibromatosis

0.00

0.0

1.2

—

Other specified and unspecified personality disorders

0.00

0.0

1.2

—

Herpesviral [herpes simplex] infections

0.00

0.0

1.2

—

Adalimumab

0.00

0.0

1.2

—

Atrophic disorders of skin

0.00

-0.00

0.0

1.1

—

Crowding of teeth, including avohilmo

0.00

-0.00

0.0

1.1

—

Carcinoma in situ of breast, intraductal

0.00

-0.00

0.0

1.2

—

Cardiac murmurs and other cardiac sounds

0.00

-0.00

0.0

1.3

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.1

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.2

—

Burns and corrosions of external body surface, specified by site

0.00

-0.00

0.0

1.2

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

1.2

—

Anorexia (incl.atypical)

0.00

-0.00

0.0

1.2

—

Diseases of pulp and periapical tissues and dental caries

1.02

-0.00

1.0

1.2

—

Thoracic aortic aneurysm

0.00

-0.00

0.0

1.2

—

Psoriatic arthropathies, ICD10

0.00

-0.00

0.0

1.2

—

Later onset COPD, excluding more controls

0.00

-0.00

0.0

1.2

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.2

—

Recurrent aphthous stomatitis , including avohilmo

0.00

-0.00

0.0

1.1

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

1.2

—

Multiple gestation

0.00

-0.00

0.0

1.0

—

Disorders of continuity of bone

0.00

-0.00

0.0

1.2

—

Macular pucker

0.00

-0.00

0.0

1.2

—

Other disorders of kidney and ureter

0.00

-0.00

0.0

1.2

—

Failed induction of labour

0.00

-0.00

0.0

1.1

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

-0.00

0.0

1.2

—

Superficial injury of hip and thigh

0.00

-0.00

0.0

1.1

—

Dental caries, including avohilmo

0.95

-0.00

1.0

1.2

—

Aneurysms, operations, SAH

0.00

-0.00

0.0

1.0

—

Certain conditions originating in the perinatal period

0.00

-0.00

0.0

1.3

—

Primary hyperparathyroidism

0.00

-0.00

0.0

1.2

—

Other superficial mycoses

0.00

-0.00

0.0

1.2

—

Other disorders of conjunctiva

0.00

-0.00

0.0

1.2

—

Use of pramipexole

0.00

-0.00

0.0

1.1

—

Other psoriatic arthropathies

0.00

-0.00

0.0

1.2

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

-0.00

0.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

1.00

-0.00

1.0

1.2

—

Abnormal spermatozoa

0.00

-0.00

0.0

1.0

—

Hydrocele

0.00

-0.00

0.0

1.0

—

Deep bite

0.00

-0.00

0.0

1.3

—

Hypertensive heart and/or renal disease

0.00

-0.00

0.0

1.1

—

AV-block

0.00

-0.00

0.0

1.0

—

Other diseases of intestine

0.00

-0.00

0.0

1.1

—

Alcohol abuse, main dg, excluding more controls

0.00

-0.00

0.0

1.2

—

Personal history of other diseases and conditions

0.00

-0.00

0.0

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.02

-0.00

1.1

1.2

—

Bitten or struck by other mammals

0.00

-0.00

0.0

1.2

—

Acute laryngitis and tracheitis

0.00

-0.00

0.0

1.2

—

Other maternal disorders predominantly related to pregnancy

0.85

-0.00

1.0

1.1

—

Speech and linguistic disorders

0.00

-0.00

0.0

1.1

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

0.00

-0.00

0.0

1.1

—

Multiple delivery

0.00

-0.00

0.0

1.2

—

Gout, strict definition

0.00

-0.00

0.0

1.1

—

L02BB Anti-androgens

0.00

-0.00

0.0

1.0

—

Other disorders of eye and adnexa

0.00

-0.00

0.0

1.1

—

Other arrhythmias

0.88

-0.00

1.0

1.1

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

-0.00

0.0

1.1

—

Other/unspecified synovitis and tenosynovitis

0.00

-0.00

0.0

1.2

—

Osteoporosis

0.00

-0.00

0.0

1.1

—

Superficial injury of forearm

0.00

-0.00

0.0

1.2

—

Other disorders of penis

0.00

-0.00

0.0

1.0

—

Trigger finger

0.00

-0.00

0.0

1.1

—

Hallux rigidus

0.00

-0.00

0.0

1.0

—

Conjunctivitis

0.88

-0.00

1.0

1.1

—

Polyarthrosis

0.00

-0.00

0.0

1.0

—

Other disorders of cornea

0.00

-0.00

0.0

1.2

—

Cardiomyopathies, Primary/intrinsic

0.00

-0.00

0.0

1.0

—

Other embolism and thrombosis

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

-0.00

0.0

1.1

—

Crohn disease

0.00

-0.00

0.0

1.2

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Other congenital malformations

0.00

-0.00

0.0

1.2

—

Valvular operations

0.00

-0.00

0.0

1.0

—

Dermatographic urticaria

0.00

-0.00

0.0

1.2

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.2

—

Family history of malignant neoplasm

0.00

-0.00

0.0

1.2

—

Arthropathic psoriasis

0.00

-0.00

0.0

1.2

—

Gonarthrosis [arthrosis of knee](FG)

0.94

-0.00

1.0

1.2

—

Assault

0.00

-0.00

0.0

1.1

—

Early lumbar disc prolapse operation

0.00

-0.00

0.0

1.0

—

Endometriosis of ovary

0.00

-0.00

0.0

1.0

—

Lichen planus

0.00

-0.00

0.0

1.2

—

Other heart diseases, wide

0.94

-0.00

1.1

—

Viral hepatitis

0.00

-0.00

0.0

1.2

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.2

—

Other bursopathies

0.00

-0.00

0.0

1.2

—

Burns and corrosions

0.00

-0.00

0.0

1.2

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein electrophoresis panel - Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS